Skip to main content

Find Clinical Trials

Home
Conditions
Shingles

Clinical trial condition

Shingles

Explore clinical trials studying Shingles. Study availability and eligibility vary by location and protocol.

30 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Shingles trial results

Completed

Valacyclovir in Immunocompromised Children

NCT00059592

Conditions: Bone Marrow Transplantation, DNA Virus Infections, Herpes Zoster, +5 more
Locations: Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Completed

Immune Response to Shingles Vaccination

NCT02624375

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +4 more
Locations: University of Washington Virology Research Clinic Seattle, Washington, United States

View Trial Details

Completed

Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)

NCT01527370

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +4 more
Locations: Not specified

View Trial Details

Completed

Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting Conditions

NCT01132729

Conditions: Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +17 more
Locations: PRACs Institute, Ltd. Fargo, North Dakota, United States

View Trial Details

Completed

Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions

NCT01132716

Conditions: Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +17 more
Locations: PRACs Institute, Ltd. Fargo, North Dakota, United States

View Trial Details

Completed

Optimal Timing of Zoster Vaccine After Zoster Illness

NCT02704572

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +4 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)

NCT01556451

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +4 more
Locations: Not specified

View Trial Details

Completed

Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1)

NCT01505647

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +4 more
Locations: Not specified

View Trial Details

Completed

Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)

NCT00534248

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +4 more
Locations: Not specified

View Trial Details

Completed

Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)

NCT00109122

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +4 more
Locations: Not specified

View Trial Details